SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000769993-20-000167
Filing Date
2020-02-14
Accepted
2020-02-14 11:33:20
Documents
1
Period of Report
2020-02-03

Document Format Files

Seq Description Document Type Size
1 ownershipdoc02112020103223.html 3  
1 ownershipdoc02112020103223.xml 3 7174
  Complete submission text file 0000769993-20-000167.txt   9509
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 2129021000
GOLDMAN SACHS & CO. LLC (Reporting) CIK: 0000769993 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-33093 | Film No.: 20615972

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Reporting) CIK: 0000886982 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-33093 | Film No.: 20615971
SIC: 6211 Security Brokers, Dealers & Flotation Companies